||||Page|
|---|---|---|---|
|Report ofthe Trustees|||1-7|
|independent<br>examiner's||report||
|Statement<br>of Financial||Activities||
|Balance Sheet|||10|
|Notes to the Financial|Statements||11-15|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



|O 0<br>Hag<br>CIIl f|O 0<br>Hag<br>CIIl f|CO <br>CG|bl<br> CO||CG<br>B <br>P <br>'0|CI4<br> CA<br> O<br> O||CIl<br>CD<br>Cl<br>CO||CV<br>CD<br>Cl<br>CO|
|---|---|---|---|---|---|---|---|---|---|---|
||'U||||||||||
|O <br>+ <br>CV|Q<br> V<br> e<br>I|CG <br>CD <br>CD<br>lA|C4<br> CO|O<br>CO<br>C)<br>CO|CO <br>CI4 <br>W|P4<br> P<br>CV<br>CO|C)<br>Cl<br>CD<br>0)|O <br>CV <br>CO <br>CO|O<br> O<br>~<br> v-|CV<br>CO<br>CO|
||'U||||||||||
|O <br>O <br>N|Q<br> V<br> v~<br> eQ|CG<br>CG<br>lA<br>O|||I|CO<br>CO|Cl<br>CO<br>CO|CO <br>O <br>CD <br>CV|O<br> O<br>~<br>~||







|||O <br>Ca(|<br>|(Q<br> 0<br> ~|~||CV<br>lA||OY)O<br>bl O lA<br>F)a-O<br>N C 8)|OY)O<br>bl O lA<br>F)a-O<br>N C 8)|OY)O<br>bl O lA<br>F)a-O<br>N C 8)|||(0<br>lA<br>O|p<br>N<br>(D||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||||CA|||||||||||
|||||Ql|||||||||||||||||||||
|||O <br>(=a<br>CV <br>(a(|<br>|V<br>fh<br> ~~ <br>D|~||CV<br>lA||OOO<br>R4 lA<br>Y) a- O<br>CV lA P)<br>P)|||O<br>O||(0<br>lA<br>PJ<br>O<br>CO|lA<br>O|(0<br>O||(0<br>O|I||||||
||||"U||||||||||||||||||||||
|||(ll<br>O<br>cu ."-<br>a'|||||||I|(V)<br>(0<br>Q)|I||||||||(0<br>CD||||||
|||Caf||fh<br>Ql||||||(0|||||||||(0||||||
||T<br>CVo|Cl<br>Ca(|((f0<br>I||||||O <br>N <br>6) <br>CV|4 <br> O <br> (D <br> CV|CV<br> (0<br> C4|||lA<br>(0||||(0|(0<br>Al<br>cO|CD<br>IA<br>(D|||||
||V||||||||||||||||||||||||
|'U|(I$||'UI||||||||||||||||||||||
|0|(0|Pv||V<br>a<br>lhI|||||O(O <br>C4 R <br>M a- <br>C4 F)||P4<br> (0<br> P4|||lAO<br>(Z&<br>CD||C4<br>CO<br>(0||cO<br>C4<br>(0||P)<br>PJ<br>(0|O||||
|UJ|fh<br>0$||CD||||||||||||||||||||||
|UD|Cl)I<br>V<br>C<br>(Q<br>(Q<br>IXI|hl<br>O<br>hl|'UI<br>V<br>'<br>~<br>fh<br>Qa<br>tL||(af||||I|(0<br>(D<br>C4|I|||OO<br>lA<br>(0|(0<br>CV<br>CV|(0<br>C4||I|CV|(0<br>P)<br>Al|||||
||||||||||||||||||||||0<br>fh6)<br>Q)|||lh<br>C<br>0VV|
||||||||||||||||||||||I-<br>(D|V<br>~X||Ql<br>lh<br>Ql|
|||Q)0|||||||||||||||||||0<br>Ul|||0|
||||||||||||||||||||||C:<br>Q)|:w|I-|(Q0.|
||||||||||||||||||||||E|||E|
||||||||||||||||||||||(0||||
|||||||||||||||I|||||||||||
|||||||||||||||(0<br>Q)|||||||(D0|||lA|
|||||||fh<br>fh +<br>fh<br>Qa<br>fh<br>lh<br>(Q<br>fh<br>g)<br>(Q—<br>'U<br>Cn<br>Ql C<br>LL I-||fhI<br>lh<br>lh<br>fl5<br>C<br>Ql <br>O|~O0<br> (O<br>0<br>(Q<br>C<br>0<br>(Q<br>(Q<br>(fl<br>(Q 0<br>fh M<br>(Q<br>(D<br>UO||||Ql<br>0<br>C<br>fh '-<br>(D 5<br>Ql<br>0<br>(I5<br>fh<br>C 0<br>L<br>UU||(h<br>lh<br>lh(5<br>C<br>Qa<br>a<br>V<br>Qa<br>Z|fh<br>4J<br>Qa<br>fh<br>fh<br>lO<br>I<br>Z|O<br>lh ~<br>C a<br>U C<br>u 0||Qp<br>O<br>fh<br>Q)<br>Cr'.||(D<br>0<br>h.<br>Ct.<br>(Q<br>Q)I<br>Q)<br>fh<br>C<br>0<br>OO<br>(Q<br>0)<br>I—|: 0|lh|0<br>fh<br>QP<br>U)<br>CL<br>C0<br>lh<br>Ql0C<br>Ql<br>I-|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

|income fr|om donati|ons<br>and legacies|||||
|---|---|---|---|---|---|---|
||||Restricted|Unrestricted|Total|Total|
||||2021|2021|2021|2020|
|||||F|||
|Donations|(including|gift aid)|46,986|15,518|62,504|57,595|
|Legacy<br>Mail shot||||1,749<br>2,183|1,749<br>2,183|548<br>215|
|Events<br>Grants —Government||Job Retention Scheme|166|3,791<br>26,010|3,957<br>26,010|28,228|
||||47,152|49,251|96,403|86,586|



## 

## 

|||||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|---|---|
|||||2021|2021|2021|2020|
||||||E|f.||
|Bladder|cancer||||||14,980|
|Prostate|cancer||||||19,893|
|Kidney cancer<br>Governance costs (see|||note 6)||5,238|5,238|9,500<br>2,188|
|Urology|related cancer||education|26,339||26,339|17,680|
|Support|||||9,511|9,511|36,211|
|OUH NHS Foundation||Trust||6,500||6,500||
|||||32,839|14,749|47,588|100,452|





## 

## 

## 

## 

||||||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|---|---|---|
||||||2021<br>E|2021f|2021<br>F|2020|
|Mail shot costs||||||1,473|1,473|666|
|Events||||||198|198|11,796|
|Support|costs|||||37,285|37,285|34,666|
|||||||38,956|38,956|47,128|
|Governance||costs|||||||
||||||Restricted|Unrestricted|Total|Total|
||||||2021<br>f.|2021|2021f|2020<br>f|
|Independent<br>review of <br>Legal and professional||||accounts<br>fees||1,720<br>1,140|1,720<br>1,140|1,974<br>214|
|Support|(including||computer costs)|||2,378|2,378||
|||||||5,238|5,238|2,188|



## 

|governance<br>and expenditur|e<br>on raising|funds on the estimate|d<br>time spent o|n each activity.||
|---|---|---|---|---|---|
|||Basis of|Charitable|Raising|Governance|
|||apportionment|activity<br>f|funds<br>f.|costs|
|Office costs<br>Salaries and administrative|support|Work due<br>Work due|2,117<br>7,394|8,469<br>28,816|530<br>1,848|
|Total resources expended|||9,511|37,285|2,378|





## 

## 

## 

## 

|Analysis ofemployee costs|||
|---|---|---|
||2021|2020|
|Salaries|36,549|49,700|
|Social security costs|685|1,470|
|Pension|1,284|2,201|
||38,518|53,371|



## 

## 

## 

## 

|Debtors||||||||
|---|---|---|---|---|---|---|---|
|||||||2021|2020|
|Gift Aid||||||262|2,375|
|Prepayments|||||||675|
|||||||262|3,050|
|Creditors due within one|||year|||||
|||||||2021|2020|
||||||||f|
|Other taxes|and social security||||||460|
|Accruals||||||1,800|1,880|
|Grants payable||||||14,505|27,916|
|||||||16,305|30,256|
|Movement|in recognised||grant commitments||during the year|||
|||||||2021f|2020<br>f.|
|Grant commitments||charged||to the SOFA||839,293|832,793|
|Grants paid||||||(824,788)|(804,877)|
|Amount ofgrant commitments||||recognised at 31stMarch||14,505|27,916|





## 

|Restricted fund|||||||
|---|---|---|---|---|---|---|
|Current year|||At 1stApril|Incoming|Outgoing|At 31st|
||||2020|resources|resources|INarch|
|||||||2021|
|Community<br>Awareness<br>Prostate cancer|project||8,036<br>500|37,716<br>2,936|(26,339)|19,413<br>3,436|
|lan Kirkham<br>Fellowship|||1,100|||1,100|
|Kidney cancer|||100|||100|
|Testicular cancer<br>OUH NHS Foundation|Trust||(773)|6,500|(6,500)|(773)|
||||8,963|47,152|(32,839)|23,276|
|Prior year|||||||
|||At 1stApril<br>2019|Incoming<br>resources|Outgoing<br>resources|Transfer|At 31st<br>March|
|||||||2020|
||||F||||
|Community<br>Awareness<br>Prostate cancer|project|2,228<br>500|23,488|(17,680)||8,036<br>500|
|lan Kirkham<br>Fellowship<br>Kidney cancer||1,100<br>100||||1,100<br>100|
|Testicular cancer<br>HIFU||(773)|17,100||(17,100)|(773)|
|||3,155|40,588|(17,680)|(17,100)|8,963|